These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 1899547

  • 1. [Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Fujimoto S, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):201-9. PubMed ID: 1899547
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity on murine tumors of a novel antitumor benzoylphenylurea derivative, HO-221.
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Fujimoto S, Tsukagoshi S, Taguchi T.
    Cancer Chemother Pharmacol; 1991 Feb; 28(5):351-6. PubMed ID: 1914078
    [Abstract] [Full Text] [Related]

  • 3. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
    [Abstract] [Full Text] [Related]

  • 4. [Antitumor effect of a benzoylphenylurea derivative HO-221].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871
    [Abstract] [Full Text] [Related]

  • 5. [Mechanism of antitumor effect of a benzoylphenylurea derivative, HO-221].
    Nakajima T, Okamoto T, Masuda H, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2345-51. PubMed ID: 2260870
    [Abstract] [Full Text] [Related]

  • 6. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 7. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K, Oka T, Morimoto M.
    Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218
    [Abstract] [Full Text] [Related]

  • 9. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct 15; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

  • 10. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
    Fujita F, Fujita M, Inaba H, Sugimoto T, Okuyama Y, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Oct 15; 18(13):2263-70. PubMed ID: 1929447
    [Abstract] [Full Text] [Related]

  • 11. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I, Stein U, Hoffmann J, Winterfeld G, Pfeil D, Hentschel M.
    Anticancer Res; 1994 Oct 15; 14(5A):1995-2003. PubMed ID: 7847840
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
    Bradner WT, Rose WC, Schurig JE, Schlein A, Huftalen JB.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5619-23. PubMed ID: 6437670
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
    Shimomura K, Manda T, Mukumoto S, Masuda K, Nakamura T, Mizota T, Matsumoto S, Nishigaki F, Oku T, Mori J.
    Cancer Res; 1988 Mar 01; 48(5):1166-72. PubMed ID: 3342397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 16. [Study for modifying activity of solvents on antitumor activity of paclitaxel].
    Fujimoto S.
    Gan To Kagaku Ryoho; 1994 Apr 15; 21(5):665-70. PubMed ID: 7908793
    [Abstract] [Full Text] [Related]

  • 17. [Antitumor activity of HO-221, a derivative of benzoylphenylurea against human cancer xenografts in nude mice].
    Fujita F, Fujita M, Inaba H, Sugimoto T, Okuyama Y, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Oct 15; 18(13):2255-61. PubMed ID: 1929446
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo characterization of P388 leukemia resistant to mitomycin C.
    Rose WC, Huftalen JB, Bradner WT, Schurig JE.
    In Vivo; 1987 Oct 15; 1(1):47-52. PubMed ID: 2979764
    [Abstract] [Full Text] [Related]

  • 20. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
    Watanabe N, Niitsu Y, Yamauchi N, Ohtsuka Y, Sone H, Neda H, Maeda M, Urushizaki I.
    Immunopharmacol Immunotoxicol; 1988 Oct 15; 10(1):117-27. PubMed ID: 2452179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.